FDA rejects Covid-19 drug over uncertainties around small trial
Following the advice of a panel of outside experts, the FDA has turned down a potential Covid-19 drug that only had data from a small …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
